Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_assertion type Assertion NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_head.
- NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_assertion description "[CK20 mRNA values in TCCB group (mean 27712.57 copies/microl) were significantly higher than in non-cancer disease urological group (mean 74.45 copies/microl) and control group (mean 8.47 copies/microl) (p < 0.001, p < 0.001, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_provenance.
- NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_assertion evidence source_evidence_literature NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_provenance.
- NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_assertion SIO_000772 19300416 NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_provenance.
- NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_assertion wasDerivedFrom befree-20150227 NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_provenance.
- NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_assertion wasGeneratedBy ECO_0000203 NP911279.RAWSANHrqnB-e2BqNcPur3kHhJdTHXMGXoNNZKLkeI9f4130_provenance.